<DOC>
	<DOCNO>NCT02984722</DOCNO>
	<brief_summary>The aim study compare different effect 6 month treatment extended-release metformin immediate-release metformin clinical , endocrine metabolic parameter woman affect polycystic ovary syndrome . We also evaluate gastrointestinal disorder associate two different compouds .</brief_summary>
	<brief_title>Extended-release v Immediate-release Metformin PCOS Women</brief_title>
	<detailed_description />
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>woman PCOS accordance Rotterdam criterion pregnancy diabetes mellitus ( impaired glucose tolerance determine standard 75 gr oral glucose tolerance test ) past history cardiovascular disease past history gastrointestinal disease significant liver renal dysfunction ( hypothalamic , pituitary , thiroidal adrenal ) ; neoplasm .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>PCOS</keyword>
	<keyword>metformin</keyword>
</DOC>